<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03335007</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2015-5-146</org_study_id>
    <nct_id>NCT03335007</nct_id>
  </id_info>
  <brief_title>Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment</brief_title>
  <official_title>Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment: A Randomized, Double-blind, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective, randomized, double-blind, clinical trial is to evaluate the
      effect of a preoperative, single, oral dose of aceclofenac (100 mg) on postendodontic pain at
      6, 24 and 48 hours, postoperative pain at injection area at 6, 24 and 48 hours and analgesic
      intake after single-visit root canal treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Patients will be clinically and radiographically examined and their eligibility will be
           assessed and preoperative pain will be measured using Heft-Parker VAS. Eligible patients
           will be treated in one visit.

        -  Patients will be randomly assigned to one of 2 groups: experimental group (taking a 100
           mg of Aceclofenac) and the control group (taking a placebo tablet). Each tablet will be
           taken one hour before the initiation of single-visit endodontic therapy. Each
           participant will receive a standard inferior alveolar nerve block injection of 1.8 ml of
           2% mepivacaine with 1:100,000 epinephrine. After endodontic treatment, patients will be
           given postoperative instructions and informed, in case of pain, to receive ibuprofen 200
           mg as rescue medication.

        -  Postendodontic pain intensity and incidence at the different pain categories (No, mild,
           moderate, severe) will be assessed 6, 24, and 48 hours postoperatively using Heft-Parker
           visual analogue scale (HP-VAS). Postoperative pain at injection area will be assessed at
           6,24 and 48 hours using HP-VAS. Analgesic intake throughout the 48 hours will be
           recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postendodontic pain rate change</measure>
    <time_frame>At 6, 24 and 48 hours after root canal treatment.</time_frame>
    <description>Postendodontic pain will be measured using Heft-Parker visual analogue scale. No or mild pain response will be considered success.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain at injection area</measure>
    <time_frame>At 6, 24 and 48 hours after root canal treatment.</time_frame>
    <description>Postoperative pain at injection area will be measured with Heft-Parker visual analogue scale. No or mild pain response will be considered success.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic intake</measure>
    <time_frame>Within 48 hours after single root canal treatment.</time_frame>
    <description>Incidence of analgesic intake</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Symptomatic Irreversible Pulpitis</condition>
  <arm_group>
    <arm_group_label>Aceclofenac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aceclofenac 100 mg tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aceclofenac</intervention_name>
    <description>Aceclofenac 100 mg tablet given one hour before starting the root canal treatment</description>
    <arm_group_label>Aceclofenac</arm_group_label>
    <other_name>Bristaflam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo tablet given one hour before starting the root canal treatment</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in good health (American Society of Anesthesiologists Class I or Class II).

          -  Patients having symptomatic irreversible pulpitis in one of their mandibular molars

          -  Age is 18 years or older.

          -  Patients who can understand Heft- Parker Visual Analogue Scales.

          -  Patients able to sign informed consent.

        Exclusion Criteria:

          -  Patients allergic to aceclofenac or Mepivacaine.

          -  Pregnant or nursing women.

          -  Patients having active pain in more than one molar in the same quadrant.

          -  Administration of analgesics within 12 h before the administration of the study drug.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nermeen A Abbas, Postgraduate</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suzan AW Amin, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shaimaa Gawdat, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Praveen R, Thakur S, Kirthiga M. Comparative Evaluation of Premedication with Ketorolac and Prednisolone on Postendodontic Pain: A Double-blind Randomized Controlled Trial. J Endod. 2017 May;43(5):667-673. doi: 10.1016/j.joen.2016.12.012. Epub 2017 Mar 17.</citation>
    <PMID>28320541</PMID>
  </reference>
  <reference>
    <citation>Attar S, Bowles WR, Baisden MK, Hodges JS, McClanahan SB. Evaluation of pretreatment analgesia and endodontic treatment for postoperative endodontic pain. J Endod. 2008 Jun;34(6):652-5. doi: 10.1016/j.joen.2008.02.017. Epub 2008 Apr 2.</citation>
    <PMID>18498882</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2017</study_first_submitted>
  <study_first_submitted_qc>November 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2017</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nermeen AwadAllah Abbas Ibrahim</investigator_full_name>
    <investigator_title>Principal Investigator, Cairo University</investigator_title>
  </responsible_party>
  <keyword>Aceclofenac</keyword>
  <keyword>pain</keyword>
  <keyword>irreversible pulpitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Aceclofenac</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

